

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | presynaptic membrane assembly (GO:0097105) | 5.72740921 |
| 2 | postsynaptic membrane organization (GO:0001941) | 5.15063337 |
| 3 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 5.07557806 |
| 4 | presynaptic membrane organization (GO:0097090) | 5.00682897 |
| 5 | vocalization behavior (GO:0071625) | 4.54395326 |
| 6 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.37565543 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 4.26939894 |
| 8 | neuronal action potential propagation (GO:0019227) | 4.24381319 |
| 9 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.20592161 |
| 10 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.10733517 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.01372144 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.01219306 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.90954415 |
| 14 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.79217147 |
| 15 | protein localization to synapse (GO:0035418) | 3.71572041 |
| 16 | startle response (GO:0001964) | 3.67645932 |
| 17 | short-term memory (GO:0007614) | 3.63772142 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.62506564 |
| 19 | negative regulation of dendrite development (GO:2000171) | 3.58953383 |
| 20 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.57674403 |
| 21 | lactate metabolic process (GO:0006089) | 3.55310762 |
| 22 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.46185433 |
| 23 | cellular potassium ion homeostasis (GO:0030007) | 3.36421382 |
| 24 | positive regulation of glycolytic process (GO:0045821) | 3.33481714 |
| 25 | transferrin transport (GO:0033572) | 3.31368481 |
| 26 | positive regulation of synapse assembly (GO:0051965) | 3.31342414 |
| 27 | phagosome maturation (GO:0090382) | 3.30978194 |
| 28 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.30931277 |
| 29 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.26155570 |
| 30 | regulation of synaptic vesicle transport (GO:1902803) | 3.24903826 |
| 31 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.19687554 |
| 32 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.18479140 |
| 33 | trivalent inorganic cation transport (GO:0072512) | 3.17525474 |
| 34 | ferric iron transport (GO:0015682) | 3.17525474 |
| 35 | glutamate secretion (GO:0014047) | 3.16957713 |
| 36 | synaptic vesicle maturation (GO:0016188) | 3.14136402 |
| 37 | positive regulation of amino acid transport (GO:0051957) | 3.12617407 |
| 38 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.11150782 |
| 39 | sodium ion export (GO:0071436) | 3.10988587 |
| 40 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.03352259 |
| 41 | neuron-neuron synaptic transmission (GO:0007270) | 3.00686724 |
| 42 | zinc ion transport (GO:0006829) | 2.96730458 |
| 43 | positive regulation of macroautophagy (GO:0016239) | 2.94804404 |
| 44 | positive regulation of protein autophosphorylation (GO:0031954) | 2.93917624 |
| 45 | synaptic transmission, glutamatergic (GO:0035249) | 2.90803811 |
| 46 | positive regulation of membrane potential (GO:0045838) | 2.88713735 |
| 47 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.88544535 |
| 48 | neurotransmitter secretion (GO:0007269) | 2.87453889 |
| 49 | negative regulation of hormone metabolic process (GO:0032351) | 2.85476312 |
| 50 | endothelium development (GO:0003158) | 2.85200792 |
| 51 | long-term synaptic potentiation (GO:0060291) | 2.83926440 |
| 52 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.82707925 |
| 53 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.82146410 |
| 54 | cerebellar granule cell differentiation (GO:0021707) | 2.81274452 |
| 55 | developmental pigmentation (GO:0048066) | 2.80667665 |
| 56 | glucosamine-containing compound catabolic process (GO:1901072) | 2.79461192 |
| 57 | exocrine pancreas development (GO:0031017) | 2.78951257 |
| 58 | superoxide anion generation (GO:0042554) | 2.77551553 |
| 59 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.75391997 |
| 60 | fatty acid homeostasis (GO:0055089) | 2.71725228 |
| 61 | glutamate receptor signaling pathway (GO:0007215) | 2.70765773 |
| 62 | inositol phosphate catabolic process (GO:0071545) | 2.70532270 |
| 63 | hyperosmotic salinity response (GO:0042538) | 2.68210353 |
| 64 | serotonin metabolic process (GO:0042428) | 2.67232156 |
| 65 | eosinophil chemotaxis (GO:0048245) | 2.66814462 |
| 66 | regulation of postsynaptic membrane potential (GO:0060078) | 2.65561897 |
| 67 | regulation of synapse assembly (GO:0051963) | 2.64568642 |
| 68 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.64467328 |
| 69 | aggressive behavior (GO:0002118) | 2.64188262 |
| 70 | membrane assembly (GO:0071709) | 2.62877646 |
| 71 | biotin metabolic process (GO:0006768) | 2.60841470 |
| 72 | long term synaptic depression (GO:0060292) | 2.60467743 |
| 73 | potassium ion import (GO:0010107) | 2.57679215 |
| 74 | regulation of neurotransmitter levels (GO:0001505) | 2.56430352 |
| 75 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.56110754 |
| 76 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.54905905 |
| 77 | serotonin receptor signaling pathway (GO:0007210) | 2.53949454 |
| 78 | ketone body metabolic process (GO:1902224) | 2.52759441 |
| 79 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.52597995 |
| 80 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.52597995 |
| 81 | gamma-aminobutyric acid transport (GO:0015812) | 2.52420997 |
| 82 | neurofilament cytoskeleton organization (GO:0060052) | 2.51956670 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 2.50454705 |
| 84 | regulation of respiratory system process (GO:0044065) | 2.50435160 |
| 85 | cochlea development (GO:0090102) | 2.50240917 |
| 86 | positive regulation of neurotransmitter transport (GO:0051590) | 2.49830345 |
| 87 | mechanosensory behavior (GO:0007638) | 2.48442753 |
| 88 | neuromuscular process controlling posture (GO:0050884) | 2.47975671 |
| 89 | potassium ion homeostasis (GO:0055075) | 2.47429092 |
| 90 | regulation of neurotransmitter secretion (GO:0046928) | 2.47329966 |
| 91 | branched-chain amino acid catabolic process (GO:0009083) | 2.46589272 |
| 92 | chemosensory behavior (GO:0007635) | 2.45570226 |
| 93 | peptidyl-cysteine modification (GO:0018198) | 2.45050021 |
| 94 | positive regulation of response to nutrient levels (GO:0032109) | 2.44148304 |
| 95 | positive regulation of response to extracellular stimulus (GO:0032106) | 2.44148304 |
| 96 | behavioral response to pain (GO:0048266) | 2.43653718 |
| 97 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.43347640 |
| 98 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.42977718 |
| 99 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.42279108 |
| 100 | female mating behavior (GO:0060180) | 2.41223707 |
| 101 | cAMP catabolic process (GO:0006198) | 2.40681365 |
| 102 | interferon-gamma production (GO:0032609) | 2.40604488 |
| 103 | long-term memory (GO:0007616) | 2.40042761 |
| 104 | negative regulation of mast cell activation (GO:0033004) | 2.39901918 |
| 105 | insulin secretion (GO:0030073) | 2.39050232 |
| 106 | learning (GO:0007612) | 2.38864320 |
| 107 | response to histamine (GO:0034776) | 2.38706978 |
| 108 | cell communication involved in cardiac conduction (GO:0086065) | 2.38345254 |
| 109 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.38225904 |
| 110 | eosinophil migration (GO:0072677) | 2.37665356 |
| 111 | protein localization to cilium (GO:0061512) | 2.37247635 |
| 112 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.36737587 |
| 113 | positive regulation of respiratory burst (GO:0060267) | 2.36583264 |
| 114 | proline transport (GO:0015824) | 2.35838980 |
| 115 | regulation of Rac protein signal transduction (GO:0035020) | 2.35222544 |
| 116 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.34045982 |
| 117 | negative regulation of cell killing (GO:0031342) | 2.34045982 |
| 118 | zinc ion transmembrane transport (GO:0071577) | 2.33439699 |
| 119 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.33385900 |
| 120 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.33215397 |
| 121 | L-phenylalanine metabolic process (GO:0006558) | 2.32398535 |
| 122 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.32398535 |
| 123 | neurotransmitter uptake (GO:0001504) | 2.31807311 |
| 124 | regulation of hexokinase activity (GO:1903299) | 2.31534083 |
| 125 | regulation of glucokinase activity (GO:0033131) | 2.31534083 |
| 126 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.29798173 |
| 127 | synapse assembly (GO:0007416) | 2.29555203 |
| 128 | neurotransmitter transport (GO:0006836) | 2.29287872 |
| 129 | L-phenylalanine catabolic process (GO:0006559) | 2.28741800 |
| 130 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.28741800 |
| 131 | vesicle docking involved in exocytosis (GO:0006904) | 2.28654775 |
| 132 | synaptic vesicle endocytosis (GO:0048488) | 2.28545707 |
| 133 | regulation of synaptic plasticity (GO:0048167) | 2.28127371 |
| 134 | regulation of female receptivity (GO:0045924) | 2.26937295 |
| 135 | signal release (GO:0023061) | 2.26380847 |
| 136 | regulation of amino acid transport (GO:0051955) | 2.25978460 |
| 137 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.25284756 |
| 138 | urinary tract smooth muscle contraction (GO:0014848) | 2.24192084 |
| 139 | lysine metabolic process (GO:0006553) | 2.24078750 |
| 140 | lysine catabolic process (GO:0006554) | 2.24078750 |
| 141 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.22348442 |
| 142 | myelin maintenance (GO:0043217) | 2.22246202 |
| 143 | innervation (GO:0060384) | 2.22233534 |
| 144 | regulation of cell communication by electrical coupling (GO:0010649) | 2.22122049 |
| 145 | vesicle docking (GO:0048278) | 2.21906626 |
| 146 | positive regulation of protein homodimerization activity (GO:0090073) | 2.21861106 |
| 147 | membrane depolarization (GO:0051899) | 2.21122582 |
| 148 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.21121980 |
| 149 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.20990385 |
| 150 | synaptic vesicle transport (GO:0048489) | 2.20916901 |
| 151 | establishment of synaptic vesicle localization (GO:0097480) | 2.20916901 |
| 152 | response to cocaine (GO:0042220) | 2.20223713 |
| 153 | nodal signaling pathway (GO:0038092) | 2.20079339 |
| 154 | cellular sodium ion homeostasis (GO:0006883) | 2.19945967 |
| 155 | cell communication by electrical coupling (GO:0010644) | 2.19709237 |
| 156 | anterior/posterior axis specification, embryo (GO:0008595) | 2.18299571 |
| 157 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.18069364 |
| 158 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.17761971 |
| 159 | transcytosis (GO:0045056) | 2.15404358 |
| 160 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.15324319 |
| 161 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.14472564 |
| 162 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.14227909 |
| 163 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.14117707 |
| 164 | negative regulation of cell fate commitment (GO:0010454) | 2.11892144 |
| 165 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.10999846 |
| 166 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.10284248 |
| 167 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.10071870 |
| 168 | cerebellar Purkinje cell layer development (GO:0021680) | 2.10052518 |
| 169 | apical protein localization (GO:0045176) | 2.09783658 |
| 170 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.09045731 |
| 171 | regulation of insulin secretion (GO:0050796) | 2.08932257 |
| 172 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.08796501 |
| 173 | L-amino acid import (GO:0043092) | 2.08221397 |
| 174 | intestinal epithelial cell development (GO:0060576) | 2.07955074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.69393286 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.14578680 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.10131915 |
| 4 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.92731437 |
| 5 | * TAF15_26573619_Chip-Seq_HEK293_Human | 2.72654244 |
| 6 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.64860956 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.59001545 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.56444086 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.54701097 |
| 10 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.46038506 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.40458431 |
| 12 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.40405976 |
| 13 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.25373762 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.22246787 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.21658972 |
| 16 | P300_19829295_ChIP-Seq_ESCs_Human | 2.15579914 |
| 17 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.11775844 |
| 18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.05343682 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.04469695 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.98566277 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.93593476 |
| 22 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.93443530 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.92555324 |
| 24 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.90760727 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.89227998 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.88308573 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.86783839 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.84194427 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.82488866 |
| 30 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.80134089 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.78252616 |
| 32 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.77981484 |
| 33 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.77516718 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.76196325 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.75109253 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.74476387 |
| 37 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73562252 |
| 38 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.71443647 |
| 39 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.71443647 |
| 40 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.70691959 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68996534 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66251648 |
| 43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.65114633 |
| 44 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.64855737 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.64308184 |
| 46 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.63593622 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62334742 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.62035988 |
| 49 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.62015297 |
| 50 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.61278381 |
| 51 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.60677858 |
| 52 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.59704792 |
| 53 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58398165 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.56119671 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.54936576 |
| 56 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.54688956 |
| 57 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.53957573 |
| 58 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.52713585 |
| 59 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.51900834 |
| 60 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.51841086 |
| 61 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.50701146 |
| 62 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.50640252 |
| 63 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.50622285 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49907866 |
| 65 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.48978169 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48785297 |
| 67 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.47711928 |
| 68 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45543469 |
| 69 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.44152127 |
| 70 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41628109 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.40673890 |
| 72 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.40218773 |
| 73 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.39129992 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.37534543 |
| 75 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.37251521 |
| 76 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.36194343 |
| 77 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.36113363 |
| 78 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.35581944 |
| 79 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.34535389 |
| 80 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.34122067 |
| 81 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.33127296 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.32870644 |
| 83 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32674432 |
| 84 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.32602056 |
| 85 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.31652946 |
| 86 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.30988869 |
| 87 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.30890881 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.30350834 |
| 89 | STAT3_23295773_ChIP-Seq_U87_Human | 1.30245573 |
| 90 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.29565618 |
| 91 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29274983 |
| 92 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28912566 |
| 93 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28795198 |
| 94 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.28012705 |
| 95 | JUN_21703547_ChIP-Seq_K562_Human | 1.27774774 |
| 96 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26109420 |
| 97 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.25754826 |
| 98 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.25242950 |
| 99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25231529 |
| 100 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.24761866 |
| 101 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24397168 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.23800697 |
| 103 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.22386862 |
| 104 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22051675 |
| 105 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21912841 |
| 106 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.21874355 |
| 107 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.21423019 |
| 108 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.20958926 |
| 109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20426180 |
| 110 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.20061663 |
| 111 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.19333118 |
| 112 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18719867 |
| 113 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18382150 |
| 114 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18334621 |
| 115 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.18136151 |
| 116 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17986738 |
| 117 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17757330 |
| 118 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17757330 |
| 119 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17696916 |
| 120 | KDM2B_26808549_Chip-Seq_REH_Human | 1.17011900 |
| 121 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16814874 |
| 122 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16198462 |
| 123 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.15563228 |
| 124 | VDR_22108803_ChIP-Seq_LS180_Human | 1.14795038 |
| 125 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.13331545 |
| 126 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.12370061 |
| 127 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12077429 |
| 128 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.11609287 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11579337 |
| 130 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.11042846 |
| 131 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10748215 |
| 132 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.10542248 |
| 133 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09872536 |
| 134 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09760328 |
| 135 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08588958 |
| 136 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.08108192 |
| 137 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.07255726 |
| 138 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04261376 |
| 139 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02635544 |
| 140 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.00435837 |
| 141 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98743201 |
| 142 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97586602 |
| 143 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96413051 |
| 144 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.94416810 |
| 145 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.92653387 |
| 146 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92212141 |
| 147 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90619895 |
| 148 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89946993 |
| 149 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89946993 |
| 150 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87904857 |
| 151 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.86798936 |
| 152 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.86770900 |
| 153 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85660197 |
| 154 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84988503 |
| 155 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84392183 |
| 156 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83621639 |
| 157 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.83534374 |
| 158 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83253182 |
| 159 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.82379702 |
| 160 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.82074319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.01993643 |
| 2 | MP0003303_peritoneal_inflammation | 3.71625676 |
| 3 | MP0001188_hyperpigmentation | 3.59861051 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.27914473 |
| 5 | MP0003724_increased_susceptibility_to | 3.12886959 |
| 6 | MP0003123_paternal_imprinting | 2.95607035 |
| 7 | MP0001986_abnormal_taste_sensitivity | 2.92037868 |
| 8 | MP0002735_abnormal_chemical_nociception | 2.75236963 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.68531197 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.67976094 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.63024049 |
| 12 | MP0009046_muscle_twitch | 2.52858028 |
| 13 | MP0009745_abnormal_behavioral_response | 2.50752435 |
| 14 | MP0003195_calcinosis | 2.49976691 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.42084233 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.34624972 |
| 17 | MP0002736_abnormal_nociception_after | 2.29371064 |
| 18 | MP0002064_seizures | 2.24999248 |
| 19 | MP0000015_abnormal_ear_pigmentation | 2.21954187 |
| 20 | MP0002876_abnormal_thyroid_physiology | 2.18682731 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.18197702 |
| 22 | MP0005646_abnormal_pituitary_gland | 2.06432501 |
| 23 | MP0003183_abnormal_peptide_metabolism | 2.05034273 |
| 24 | MP0003283_abnormal_digestive_organ | 2.03649719 |
| 25 | MP0003879_abnormal_hair_cell | 2.03110360 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 2.02905262 |
| 27 | MP0004270_analgesia | 1.98958476 |
| 28 | MP0002063_abnormal_learning/memory/cond | 1.98384727 |
| 29 | MP0002734_abnormal_mechanical_nocicepti | 1.97118776 |
| 30 | MP0005409_darkened_coat_color | 1.95409615 |
| 31 | MP0008057_abnormal_DNA_replication | 1.93418002 |
| 32 | MP0002090_abnormal_vision | 1.92208923 |
| 33 | MP0003136_yellow_coat_color | 1.89261328 |
| 34 | MP0002272_abnormal_nervous_system | 1.86120845 |
| 35 | MP0002254_reproductive_system_inflammat | 1.83278332 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.80763558 |
| 37 | MP0009672_abnormal_birth_weight | 1.76522737 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.73797250 |
| 39 | MP0005171_absent_coat_pigmentation | 1.67854589 |
| 40 | MP0001486_abnormal_startle_reflex | 1.65544175 |
| 41 | MP0005220_abnormal_exocrine_pancreas | 1.59207110 |
| 42 | MP0001970_abnormal_pain_threshold | 1.57288904 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.57013403 |
| 44 | MP0003787_abnormal_imprinting | 1.54690585 |
| 45 | MP0005174_abnormal_tail_pigmentation | 1.50697587 |
| 46 | MP0001944_abnormal_pancreas_morphology | 1.49866787 |
| 47 | MP0000372_irregular_coat_pigmentation | 1.47573334 |
| 48 | MP0010386_abnormal_urinary_bladder | 1.47081234 |
| 49 | MP0001984_abnormal_olfaction | 1.46144276 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.45865375 |
| 51 | MP0009780_abnormal_chondrocyte_physiolo | 1.45470413 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.44059519 |
| 53 | MP0005671_abnormal_response_to | 1.42181362 |
| 54 | MP0004742_abnormal_vestibular_system | 1.40584604 |
| 55 | MP0004142_abnormal_muscle_tone | 1.34588631 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.32583598 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.29843381 |
| 58 | MP0005423_abnormal_somatic_nervous | 1.27998073 |
| 59 | MP0002095_abnormal_skin_pigmentation | 1.27891507 |
| 60 | MP0010678_abnormal_skin_adnexa | 1.25761830 |
| 61 | MP0008569_lethality_at_weaning | 1.25369021 |
| 62 | MP0002733_abnormal_thermal_nociception | 1.25274164 |
| 63 | MP0001542_abnormal_bone_strength | 1.24405054 |
| 64 | MP0003121_genomic_imprinting | 1.22739776 |
| 65 | MP0003718_maternal_effect | 1.21183845 |
| 66 | MP0003828_pulmonary_edema | 1.20487877 |
| 67 | MP0002938_white_spotting | 1.17922767 |
| 68 | MP0002163_abnormal_gland_morphology | 1.15707202 |
| 69 | MP0001905_abnormal_dopamine_level | 1.14431081 |
| 70 | MP0000681_abnormal_thyroid_gland | 1.12898787 |
| 71 | MP0000778_abnormal_nervous_system | 1.12878508 |
| 72 | MP0003941_abnormal_skin_development | 1.11388509 |
| 73 | MP0004147_increased_porphyrin_level | 1.10922025 |
| 74 | MP0002693_abnormal_pancreas_physiology | 1.10128272 |
| 75 | MP0009703_decreased_birth_body | 1.09304153 |
| 76 | MP0002160_abnormal_reproductive_system | 1.04744362 |
| 77 | MP0001485_abnormal_pinna_reflex | 1.04039711 |
| 78 | MP0008058_abnormal_DNA_repair | 1.03246481 |
| 79 | MP0002184_abnormal_innervation | 1.01794718 |
| 80 | MP0005551_abnormal_eye_electrophysiolog | 1.00345917 |
| 81 | MP0001835_abnormal_antigen_presentation | 0.99991669 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.98887912 |
| 83 | MP0005365_abnormal_bile_salt | 0.98518147 |
| 84 | MP0001177_atelectasis | 0.98486505 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.98213381 |
| 86 | MP0005332_abnormal_amino_acid | 0.98090138 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.97993757 |
| 88 | MP0005000_abnormal_immune_tolerance | 0.94782658 |
| 89 | MP0004043_abnormal_pH_regulation | 0.94369572 |
| 90 | MP0005310_abnormal_salivary_gland | 0.93196941 |
| 91 | MP0005408_hypopigmentation | 0.91008641 |
| 92 | MP0001440_abnormal_grooming_behavior | 0.90967815 |
| 93 | MP0002882_abnormal_neuron_morphology | 0.89765966 |
| 94 | MP0004133_heterotaxia | 0.89490226 |
| 95 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89120228 |
| 96 | MP0003119_abnormal_digestive_system | 0.88796070 |
| 97 | MP0004811_abnormal_neuron_physiology | 0.88505374 |
| 98 | MP0001346_abnormal_lacrimal_gland | 0.88438075 |
| 99 | MP0004924_abnormal_behavior | 0.88436768 |
| 100 | MP0005386_behavior/neurological_phenoty | 0.88436768 |
| 101 | MP0001502_abnormal_circadian_rhythm | 0.87228132 |
| 102 | MP0005636_abnormal_mineral_homeostasis | 0.86711319 |
| 103 | MP0002822_catalepsy | 0.85894722 |
| 104 | MP0010329_abnormal_lipoprotein_level | 0.85496617 |
| 105 | MP0000026_abnormal_inner_ear | 0.85418443 |
| 106 | MP0003890_abnormal_embryonic-extraembry | 0.85397917 |
| 107 | MP0001756_abnormal_urination | 0.85250344 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.85233273 |
| 109 | MP0000516_abnormal_urinary_system | 0.85048318 |
| 110 | MP0005367_renal/urinary_system_phenotyp | 0.85048318 |
| 111 | MP0005379_endocrine/exocrine_gland_phen | 0.84745617 |
| 112 | MP0008260_abnormal_autophagy | 0.84739571 |
| 113 | MP0003633_abnormal_nervous_system | 0.84582824 |
| 114 | MP0001919_abnormal_reproductive_system | 0.83963374 |
| 115 | MP0003690_abnormal_glial_cell | 0.83772896 |
| 116 | MP0002102_abnormal_ear_morphology | 0.83069803 |
| 117 | MP0002066_abnormal_motor_capabilities/c | 0.82882074 |
| 118 | MP0001663_abnormal_digestive_system | 0.80868390 |
| 119 | MP0000462_abnormal_digestive_system | 0.80270306 |
| 120 | MP0002078_abnormal_glucose_homeostasis | 0.79382103 |
| 121 | MP0000639_abnormal_adrenal_gland | 0.78917606 |
| 122 | MP0001790_abnormal_immune_system | 0.78876065 |
| 123 | MP0005387_immune_system_phenotype | 0.78876065 |
| 124 | MP0003631_nervous_system_phenotype | 0.78567156 |
| 125 | MP0000569_abnormal_digit_pigmentation | 0.78383588 |
| 126 | MP0002419_abnormal_innate_immunity | 0.78172168 |
| 127 | MP0002229_neurodegeneration | 0.77586196 |
| 128 | MP0006292_abnormal_olfactory_placode | 0.76674769 |
| 129 | MP0003436_decreased_susceptibility_to | 0.75846876 |
| 130 | MP0003953_abnormal_hormone_level | 0.74022467 |
| 131 | MP0004019_abnormal_vitamin_homeostasis | 0.73555600 |
| 132 | MP0008004_abnormal_stomach_pH | 0.71887277 |
| 133 | MP0003122_maternal_imprinting | 0.71127333 |
| 134 | MP0009785_altered_susceptibility_to | 0.70244774 |
| 135 | MP0004381_abnormal_hair_follicle | 0.69647850 |
| 136 | MP0002998_abnormal_bone_remodeling | 0.69640605 |
| 137 | MP0002138_abnormal_hepatobiliary_system | 0.69542218 |
| 138 | MP0000383_abnormal_hair_follicle | 0.69490749 |
| 139 | MP0003943_abnormal_hepatobiliary_system | 0.68608453 |
| 140 | MP0004510_myositis | 0.68447324 |
| 141 | MP0000631_abnormal_neuroendocrine_gland | 0.67239211 |
| 142 | MP0002877_abnormal_melanocyte_morpholog | 0.66635101 |
| 143 | MP0005167_abnormal_blood-brain_barrier | 0.66132470 |
| 144 | MP0005075_abnormal_melanosome_morpholog | 0.66070597 |
| 145 | MP0006082_CNS_inflammation | 0.66064584 |
| 146 | MP0008872_abnormal_physiological_respon | 0.65881090 |
| 147 | MP0002420_abnormal_adaptive_immunity | 0.65628803 |
| 148 | MP0001819_abnormal_immune_cell | 0.65363758 |
| 149 | MP0000955_abnormal_spinal_cord | 0.65028476 |
| 150 | MP0002751_abnormal_autonomic_nervous | 0.64813891 |
| 151 | MP0001731_abnormal_postnatal_growth | 0.64366380 |
| 152 | MP0001666_abnormal_nutrient_absorption | 0.63918019 |
| 153 | MP0006035_abnormal_mitochondrial_morpho | 0.63583459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic seizures (HP:0002173) | 6.41613926 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.34457253 |
| 3 | Focal motor seizures (HP:0011153) | 6.18377905 |
| 4 | Febrile seizures (HP:0002373) | 5.29865954 |
| 5 | Hypoglycemic coma (HP:0001325) | 5.21514263 |
| 6 | Pancreatic islet-cell hyperplasia (HP:0004510) | 5.06013304 |
| 7 | Atonic seizures (HP:0010819) | 4.85692387 |
| 8 | Epileptic encephalopathy (HP:0200134) | 4.80947889 |
| 9 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.60574911 |
| 10 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.60574911 |
| 11 | Ketoacidosis (HP:0001993) | 4.58183282 |
| 12 | Hyperventilation (HP:0002883) | 4.27140032 |
| 13 | Symptomatic seizures (HP:0011145) | 4.21302886 |
| 14 | Hyperglycemia (HP:0003074) | 4.03985530 |
| 15 | Abnormal hair whorl (HP:0010721) | 3.97835914 |
| 16 | Hypothermia (HP:0002045) | 3.91707839 |
| 17 | Focal seizures (HP:0007359) | 3.50096593 |
| 18 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.14084239 |
| 19 | Enlarged penis (HP:0000040) | 3.04455816 |
| 20 | Absence seizures (HP:0002121) | 3.02371099 |
| 21 | Abnormal pupillary function (HP:0007686) | 3.00510282 |
| 22 | Congenital sensorineural hearing impairment (HP:0008527) | 2.98473871 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.98425783 |
| 24 | Obstructive lung disease (HP:0006536) | 2.98425783 |
| 25 | Stomatitis (HP:0010280) | 2.94242839 |
| 26 | Submucous cleft hard palate (HP:0000176) | 2.93989797 |
| 27 | Obstructive sleep apnea (HP:0002870) | 2.88881239 |
| 28 | Dialeptic seizures (HP:0011146) | 2.86417408 |
| 29 | Medial flaring of the eyebrow (HP:0010747) | 2.82597239 |
| 30 | Epileptiform EEG discharges (HP:0011182) | 2.80709501 |
| 31 | Ketosis (HP:0001946) | 2.78508388 |
| 32 | Progressive cerebellar ataxia (HP:0002073) | 2.76685644 |
| 33 | Large for gestational age (HP:0001520) | 2.76129927 |
| 34 | Broad-based gait (HP:0002136) | 2.72634792 |
| 35 | Abnormality of dental color (HP:0011073) | 2.72002340 |
| 36 | Sleep apnea (HP:0010535) | 2.70458767 |
| 37 | Gaze-evoked nystagmus (HP:0000640) | 2.69151433 |
| 38 | EEG with generalized epileptiform discharges (HP:0011198) | 2.68028340 |
| 39 | Hyperthyroidism (HP:0000836) | 2.66306235 |
| 40 | Hypomagnesemia (HP:0002917) | 2.55221313 |
| 41 | Eczematoid dermatitis (HP:0000976) | 2.55115390 |
| 42 | Hypsarrhythmia (HP:0002521) | 2.54040431 |
| 43 | Neoplasm of the adrenal cortex (HP:0100641) | 2.53979680 |
| 44 | Nephrogenic diabetes insipidus (HP:0009806) | 2.52674452 |
| 45 | Progressive inability to walk (HP:0002505) | 2.52240395 |
| 46 | Gait imbalance (HP:0002141) | 2.45312840 |
| 47 | Recurrent abscess formation (HP:0002722) | 2.45297189 |
| 48 | Polyphagia (HP:0002591) | 2.37472819 |
| 49 | Generalized tonic-clonic seizures (HP:0002069) | 2.36803058 |
| 50 | Agitation (HP:0000713) | 2.35907703 |
| 51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.35484740 |
| 52 | Inability to walk (HP:0002540) | 2.34815034 |
| 53 | Cerebral hypomyelination (HP:0006808) | 2.34083926 |
| 54 | Congenital primary aphakia (HP:0007707) | 2.33682816 |
| 55 | Blue irides (HP:0000635) | 2.33201538 |
| 56 | Neoplasm of the adrenal gland (HP:0100631) | 2.31424806 |
| 57 | Protruding tongue (HP:0010808) | 2.29242098 |
| 58 | Abnormal eating behavior (HP:0100738) | 2.29103416 |
| 59 | Sensory axonal neuropathy (HP:0003390) | 2.26006719 |
| 60 | Hypokinesia (HP:0002375) | 2.24265991 |
| 61 | Failure to thrive in infancy (HP:0001531) | 2.24225592 |
| 62 | Generalized hypopigmentation of hair (HP:0011358) | 2.23934487 |
| 63 | Chronic bronchitis (HP:0004469) | 2.21537576 |
| 64 | Ependymoma (HP:0002888) | 2.17844549 |
| 65 | Intention tremor (HP:0002080) | 2.17271018 |
| 66 | Fair hair (HP:0002286) | 2.16622278 |
| 67 | Abnormality of methionine metabolism (HP:0010901) | 2.15845859 |
| 68 | Action tremor (HP:0002345) | 2.14119666 |
| 69 | Muscular hypotonia of the trunk (HP:0008936) | 2.12023536 |
| 70 | Thyroid-stimulating hormone excess (HP:0002925) | 2.11795131 |
| 71 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.11426353 |
| 72 | Prominent metopic ridge (HP:0005487) | 2.09034144 |
| 73 | Curly hair (HP:0002212) | 2.08542517 |
| 74 | Absent speech (HP:0001344) | 2.08187014 |
| 75 | Dysdiadochokinesis (HP:0002075) | 2.06956497 |
| 76 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.02997105 |
| 77 | Severe visual impairment (HP:0001141) | 2.01042775 |
| 78 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.99775406 |
| 79 | Drooling (HP:0002307) | 1.99625317 |
| 80 | Excessive salivation (HP:0003781) | 1.99625317 |
| 81 | Hemiparesis (HP:0001269) | 1.99410504 |
| 82 | Late onset (HP:0003584) | 1.98673137 |
| 83 | Recurrent bacterial skin infections (HP:0005406) | 1.97092493 |
| 84 | Hip dysplasia (HP:0001385) | 1.96366046 |
| 85 | Poor suck (HP:0002033) | 1.94980693 |
| 86 | Increased circulating renin level (HP:0000848) | 1.94328380 |
| 87 | Ankle clonus (HP:0011448) | 1.92069536 |
| 88 | CNS hypomyelination (HP:0003429) | 1.91888489 |
| 89 | Upper limb muscle weakness (HP:0003484) | 1.91270567 |
| 90 | Abnormality of the corticospinal tract (HP:0002492) | 1.89029828 |
| 91 | Myokymia (HP:0002411) | 1.88810476 |
| 92 | Distal lower limb amyotrophy (HP:0008944) | 1.88596563 |
| 93 | Hyperphosphatemia (HP:0002905) | 1.88224001 |
| 94 | Iris hypopigmentation (HP:0007730) | 1.88184424 |
| 95 | Asymmetry of the thorax (HP:0001555) | 1.86401308 |
| 96 | Abnormality of the labia minora (HP:0012880) | 1.85077965 |
| 97 | Rhinitis (HP:0012384) | 1.84751867 |
| 98 | Hepatoblastoma (HP:0002884) | 1.84734430 |
| 99 | Mutism (HP:0002300) | 1.83968684 |
| 100 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.83404168 |
| 101 | Recurrent cutaneous fungal infections (HP:0011370) | 1.83404168 |
| 102 | Status epilepticus (HP:0002133) | 1.82761853 |
| 103 | Intrahepatic cholestasis (HP:0001406) | 1.82609859 |
| 104 | Abnormality of magnesium homeostasis (HP:0004921) | 1.81208085 |
| 105 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.81110589 |
| 106 | Choreoathetosis (HP:0001266) | 1.80585494 |
| 107 | Decreased circulating renin level (HP:0003351) | 1.79944604 |
| 108 | Abnormality of incisor morphology (HP:0011063) | 1.79682851 |
| 109 | Diminished movement (HP:0002374) | 1.79516770 |
| 110 | Anxiety (HP:0000739) | 1.79459934 |
| 111 | Thyroid carcinoma (HP:0002890) | 1.79180502 |
| 112 | Optic disc pallor (HP:0000543) | 1.78615140 |
| 113 | Attenuation of retinal blood vessels (HP:0007843) | 1.74505436 |
| 114 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.74233660 |
| 115 | Ulnar claw (HP:0001178) | 1.74127474 |
| 116 | Breast carcinoma (HP:0003002) | 1.73755411 |
| 117 | Bradycardia (HP:0001662) | 1.73667185 |
| 118 | Anal stenosis (HP:0002025) | 1.73627044 |
| 119 | Glioma (HP:0009733) | 1.72621581 |
| 120 | Poor coordination (HP:0002370) | 1.71046492 |
| 121 | Scanning speech (HP:0002168) | 1.70711964 |
| 122 | Meningitis (HP:0001287) | 1.70656321 |
| 123 | Alveolar cell carcinoma (HP:0006519) | 1.69065216 |
| 124 | Lower limb amyotrophy (HP:0007210) | 1.68870368 |
| 125 | Inappropriate behavior (HP:0000719) | 1.68655813 |
| 126 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.68107268 |
| 127 | Abnormality of binocular vision (HP:0011514) | 1.67844641 |
| 128 | Diplopia (HP:0000651) | 1.67844641 |
| 129 | Amblyopia (HP:0000646) | 1.67786219 |
| 130 | Prostate neoplasm (HP:0100787) | 1.67679358 |
| 131 | Fetal akinesia sequence (HP:0001989) | 1.66552344 |
| 132 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.66519117 |
| 133 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.66519117 |
| 134 | Optic nerve hypoplasia (HP:0000609) | 1.66434512 |
| 135 | Astrocytoma (HP:0009592) | 1.64920040 |
| 136 | Abnormality of the astrocytes (HP:0100707) | 1.64920040 |
| 137 | Neuroendocrine neoplasm (HP:0100634) | 1.64826969 |
| 138 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.64689713 |
| 139 | Homocystinuria (HP:0002156) | 1.64325005 |
| 140 | Abnormality of homocysteine metabolism (HP:0010919) | 1.64325005 |
| 141 | Megaloblastic anemia (HP:0001889) | 1.64318045 |
| 142 | Vacuolated lymphocytes (HP:0001922) | 1.64010240 |
| 143 | Absent eyebrow (HP:0002223) | 1.63533799 |
| 144 | Abnormality of salivation (HP:0100755) | 1.62721377 |
| 145 | Lower limb asymmetry (HP:0100559) | 1.61730033 |
| 146 | True hermaphroditism (HP:0010459) | 1.61511916 |
| 147 | Dyschromatopsia (HP:0007641) | 1.61302242 |
| 148 | Visual hallucinations (HP:0002367) | 1.61057894 |
| 149 | Dysmetria (HP:0001310) | 1.60413558 |
| 150 | Retrobulbar optic neuritis (HP:0100654) | 1.59813056 |
| 151 | Optic neuritis (HP:0100653) | 1.59813056 |
| 152 | Asthma (HP:0002099) | 1.59388515 |
| 153 | Hyperactive renin-angiotensin system (HP:0000841) | 1.59158829 |
| 154 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.58810290 |
| 155 | Hypoplasia of the fovea (HP:0007750) | 1.58810290 |
| 156 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.58073068 |
| 157 | Absent/shortened dynein arms (HP:0200106) | 1.58073068 |
| 158 | Truncal ataxia (HP:0002078) | 1.57910623 |
| 159 | Aqueductal stenosis (HP:0002410) | 1.57782341 |
| 160 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.56587733 |
| 161 | Agammaglobulinemia (HP:0004432) | 1.55912755 |
| 162 | Pheochromocytoma (HP:0002666) | 1.54676454 |
| 163 | Abnormality of the metopic suture (HP:0005556) | 1.53996282 |
| 164 | Recurrent fungal infections (HP:0002841) | 1.53589744 |
| 165 | Urethral obstruction (HP:0000796) | 1.53425889 |
| 166 | White forelock (HP:0002211) | 1.52935071 |
| 167 | Decreased central vision (HP:0007663) | 1.52894263 |
| 168 | Tongue fasciculations (HP:0001308) | 1.52445217 |
| 169 | Narrow nasal bridge (HP:0000446) | 1.51662783 |
| 170 | Generalized myoclonic seizures (HP:0002123) | 1.51522490 |
| 171 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.51190918 |
| 172 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.51190918 |
| 173 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.51076501 |
| 174 | Impaired vibratory sensation (HP:0002495) | 1.50901480 |
| 175 | Hamartoma of the eye (HP:0010568) | 1.49550524 |
| 176 | Papillary thyroid carcinoma (HP:0002895) | 1.48805373 |
| 177 | Macroorchidism (HP:0000053) | 1.48717955 |
| 178 | Neoplasm of the thyroid gland (HP:0100031) | 1.48265240 |
| 179 | Spastic tetraparesis (HP:0001285) | 1.47209159 |
| 180 | Methylmalonic acidemia (HP:0002912) | 1.46320529 |
| 181 | Hyperglycinuria (HP:0003108) | 1.45690209 |
| 182 | Nuclear cataract (HP:0100018) | 1.45521209 |
| 183 | Spastic gait (HP:0002064) | 1.45423390 |
| 184 | Torticollis (HP:0000473) | 1.42272862 |
| 185 | Impaired smooth pursuit (HP:0007772) | 1.42086462 |
| 186 | Embryonal renal neoplasm (HP:0011794) | 1.41954694 |
| 187 | Abnormal ciliary motility (HP:0012262) | 1.41087747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 7.23645966 |
| 2 | PRPF4B | 3.71900956 |
| 3 | FGFR2 | 3.52924739 |
| 4 | FES | 3.34797152 |
| 5 | INSRR | 3.24100311 |
| 6 | MKNK2 | 2.85362440 |
| 7 | MAP3K12 | 2.80027489 |
| 8 | MAP2K7 | 2.72438761 |
| 9 | NTRK3 | 2.23151340 |
| 10 | TRIM28 | 2.17540622 |
| 11 | AKT3 | 2.04647075 |
| 12 | TXK | 1.98618183 |
| 13 | MINK1 | 1.93715928 |
| 14 | PLK3 | 1.87738313 |
| 15 | SCYL2 | 1.86250480 |
| 16 | SIK3 | 1.78392076 |
| 17 | MAP3K2 | 1.77553000 |
| 18 | FER | 1.75869906 |
| 19 | TLK1 | 1.73216068 |
| 20 | TTK | 1.72469841 |
| 21 | RIPK4 | 1.68691634 |
| 22 | YES1 | 1.62815282 |
| 23 | SGK2 | 1.60336731 |
| 24 | MAP3K4 | 1.57255460 |
| 25 | CDK19 | 1.56867797 |
| 26 | STK38L | 1.50399588 |
| 27 | IRAK4 | 1.47543418 |
| 28 | PIM2 | 1.46067013 |
| 29 | BMPR2 | 1.45229491 |
| 30 | MAP3K9 | 1.44813859 |
| 31 | BLK | 1.44223219 |
| 32 | PLK2 | 1.42675269 |
| 33 | ADRBK2 | 1.42477801 |
| 34 | DAPK2 | 1.35502470 |
| 35 | TAF1 | 1.34412637 |
| 36 | MKNK1 | 1.28516842 |
| 37 | PAK6 | 1.27748598 |
| 38 | LATS2 | 1.27137481 |
| 39 | BRSK2 | 1.24816977 |
| 40 | PBK | 1.19702212 |
| 41 | ALK | 1.19432112 |
| 42 | PASK | 1.17599504 |
| 43 | MAP3K14 | 1.17582543 |
| 44 | CAMK1G | 1.16986671 |
| 45 | CDK8 | 1.16912435 |
| 46 | GRK7 | 1.16766406 |
| 47 | EIF2AK1 | 1.13451883 |
| 48 | NEK9 | 1.12663017 |
| 49 | TNIK | 1.12326136 |
| 50 | ACVR1B | 1.10665638 |
| 51 | UHMK1 | 1.10606139 |
| 52 | SGK494 | 1.10180008 |
| 53 | SGK223 | 1.10180008 |
| 54 | BMPR1B | 1.03952252 |
| 55 | TEC | 1.02356017 |
| 56 | OXSR1 | 1.01026772 |
| 57 | CAMK1D | 0.99682073 |
| 58 | PHKG2 | 0.98085576 |
| 59 | PHKG1 | 0.98085576 |
| 60 | STK38 | 0.97443562 |
| 61 | MST4 | 0.95969672 |
| 62 | MAPKAPK3 | 0.93270990 |
| 63 | MAPK13 | 0.92055372 |
| 64 | CAMKK2 | 0.91937781 |
| 65 | MAP4K2 | 0.91842489 |
| 66 | BRSK1 | 0.89866046 |
| 67 | GRK5 | 0.89086110 |
| 68 | PNCK | 0.88677436 |
| 69 | PINK1 | 0.86915668 |
| 70 | DAPK1 | 0.86603302 |
| 71 | SGK3 | 0.86123519 |
| 72 | STK3 | 0.85644555 |
| 73 | VRK2 | 0.84600891 |
| 74 | RPS6KB2 | 0.84242854 |
| 75 | CSK | 0.82888827 |
| 76 | ZAK | 0.81641493 |
| 77 | PRKCE | 0.81597858 |
| 78 | ADRBK1 | 0.81393113 |
| 79 | IRAK1 | 0.80180024 |
| 80 | CCNB1 | 0.76339896 |
| 81 | PAK3 | 0.76102922 |
| 82 | CSNK1G1 | 0.73537315 |
| 83 | CAMK2A | 0.72873681 |
| 84 | IRAK3 | 0.72257051 |
| 85 | MAP2K4 | 0.69933717 |
| 86 | CSNK1E | 0.69419871 |
| 87 | CSNK1G2 | 0.69300626 |
| 88 | EPHA4 | 0.69009158 |
| 89 | STK16 | 0.68590945 |
| 90 | WNK3 | 0.66901868 |
| 91 | EEF2K | 0.65694623 |
| 92 | LMTK2 | 0.64297900 |
| 93 | TSSK6 | 0.62895552 |
| 94 | LATS1 | 0.62710794 |
| 95 | MUSK | 0.62634392 |
| 96 | GRK1 | 0.62341962 |
| 97 | DYRK1A | 0.61101461 |
| 98 | NLK | 0.60520858 |
| 99 | CLK1 | 0.60334425 |
| 100 | EIF2AK3 | 0.59247647 |
| 101 | FRK | 0.59010640 |
| 102 | SYK | 0.58441869 |
| 103 | PRKCI | 0.58253130 |
| 104 | IRAK2 | 0.58239177 |
| 105 | LCK | 0.58163250 |
| 106 | MAPKAPK5 | 0.57725068 |
| 107 | DMPK | 0.57149374 |
| 108 | DAPK3 | 0.56661062 |
| 109 | BCR | 0.56600186 |
| 110 | KIT | 0.53555849 |
| 111 | CDK3 | 0.53306506 |
| 112 | CAMKK1 | 0.53281158 |
| 113 | PRKCG | 0.51880144 |
| 114 | AKT2 | 0.51688903 |
| 115 | STK39 | 0.51253859 |
| 116 | WNK1 | 0.51158867 |
| 117 | TAOK3 | 0.51139422 |
| 118 | CAMK1 | 0.51033898 |
| 119 | CDK9 | 0.51031759 |
| 120 | PLK1 | 0.50930039 |
| 121 | NUAK1 | 0.50680637 |
| 122 | SMG1 | 0.50000329 |
| 123 | CAMK2B | 0.49023907 |
| 124 | HCK | 0.45709825 |
| 125 | FGFR1 | 0.45672684 |
| 126 | STK24 | 0.45606519 |
| 127 | MARK1 | 0.45529350 |
| 128 | RPS6KB1 | 0.45508340 |
| 129 | PRKAA1 | 0.45105848 |
| 130 | CSNK1G3 | 0.44421074 |
| 131 | NEK6 | 0.44061389 |
| 132 | CDK5 | 0.43261305 |
| 133 | PRKD3 | 0.43160335 |
| 134 | STK11 | 0.43084215 |
| 135 | WNK4 | 0.42955475 |
| 136 | ATM | 0.42322982 |
| 137 | PRKDC | 0.41630227 |
| 138 | FGFR3 | 0.41143230 |
| 139 | LYN | 0.41018997 |
| 140 | HIPK2 | 0.40657476 |
| 141 | PKN1 | 0.40650284 |
| 142 | TNK2 | 0.40209089 |
| 143 | MAPK10 | 0.40086400 |
| 144 | CAMK2G | 0.40077364 |
| 145 | NTRK2 | 0.38802972 |
| 146 | RPS6KA2 | 0.38705868 |
| 147 | EPHA2 | 0.38372477 |
| 148 | FGR | 0.38096478 |
| 149 | NME1 | 0.37353613 |
| 150 | IKBKE | 0.37222507 |
| 151 | MAPK4 | 0.35158113 |
| 152 | SGK1 | 0.34028042 |
| 153 | PRKG1 | 0.33418448 |
| 154 | BRAF | 0.33037423 |
| 155 | PIK3CA | 0.32997269 |
| 156 | PTK2B | 0.32498535 |
| 157 | CAMK2D | 0.31681104 |
| 158 | EIF2AK2 | 0.29657311 |
| 159 | FYN | 0.28521074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.53510063 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.40677102 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.37206556 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.11480574 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 3.07814458 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.26412558 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.13851070 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.13402793 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.06941060 |
| 10 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.04230068 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 2.02081702 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.98395634 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.93491512 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 1.84339620 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.78670831 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.78068184 |
| 17 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74929447 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.74351614 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.74032797 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.70635760 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68625760 |
| 22 | Circadian entrainment_Homo sapiens_hsa04713 | 1.67689710 |
| 23 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.64625509 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63290362 |
| 25 | Long-term potentiation_Homo sapiens_hsa04720 | 1.63246848 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57401927 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.57106572 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.55776071 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.55130762 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.52196292 |
| 31 | Protein export_Homo sapiens_hsa03060 | 1.51839009 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.50722222 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.49887850 |
| 34 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.41817988 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.41013482 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.39891406 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.39886832 |
| 38 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.29019676 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.27428620 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.24984120 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23116392 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.22600664 |
| 43 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.22022344 |
| 44 | Salivary secretion_Homo sapiens_hsa04970 | 1.19424244 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15338711 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14525203 |
| 47 | Insulin secretion_Homo sapiens_hsa04911 | 1.12899537 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.10756721 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.07163575 |
| 50 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.06910702 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06337973 |
| 52 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03725577 |
| 53 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.03210981 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.01709392 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01678620 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.98810621 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98512676 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.98338157 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 0.98143068 |
| 60 | Histidine metabolism_Homo sapiens_hsa00340 | 0.98017749 |
| 61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.97993693 |
| 62 | Melanoma_Homo sapiens_hsa05218 | 0.97077593 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96709912 |
| 64 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.96359864 |
| 65 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.94978991 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.93768393 |
| 67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93397031 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92853763 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91023512 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90390610 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.88196758 |
| 72 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.87669550 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.87529283 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87261452 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86627997 |
| 76 | Tuberculosis_Homo sapiens_hsa05152 | 0.86327411 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85121151 |
| 78 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84580478 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.83729245 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.83330296 |
| 81 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83198440 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.82109993 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82014845 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81400596 |
| 85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.81075114 |
| 86 | Axon guidance_Homo sapiens_hsa04360 | 0.80207585 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.79986915 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79555333 |
| 89 | Tight junction_Homo sapiens_hsa04530 | 0.79122457 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.77934197 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76654669 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76264113 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76059024 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75717933 |
| 95 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75262744 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.74700555 |
| 97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.73354687 |
| 98 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73198422 |
| 99 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.73182126 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.72999796 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71319658 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.71206209 |
| 103 | Cocaine addiction_Homo sapiens_hsa05030 | 0.70036251 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68754627 |
| 105 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67432297 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66915120 |
| 107 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66145013 |
| 108 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65515061 |
| 109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65163530 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64978737 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.63905753 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63190883 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62744532 |
| 114 | Measles_Homo sapiens_hsa05162 | 0.62638217 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.62603056 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | 0.61665240 |
| 117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61419091 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61293574 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60833705 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.60223972 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60111309 |
| 122 | Lysine degradation_Homo sapiens_hsa00310 | 0.59451003 |
| 123 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58336726 |
| 124 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58146478 |
| 125 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.57928099 |
| 126 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.57248073 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57137082 |
| 128 | Melanogenesis_Homo sapiens_hsa04916 | 0.56967263 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56780985 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56490581 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56388647 |
| 132 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56150989 |
| 133 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55827005 |
| 134 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55138307 |
| 135 | Endocytosis_Homo sapiens_hsa04144 | 0.55137983 |
| 136 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53848025 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53305725 |
| 138 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53257242 |
| 139 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52856345 |
| 140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50490033 |
| 141 | Alzheimers disease_Homo sapiens_hsa05010 | 0.50431177 |
| 142 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49349586 |
| 143 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49341077 |
| 144 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49158621 |
| 145 | Hepatitis C_Homo sapiens_hsa05160 | 0.48833742 |
| 146 | Lysosome_Homo sapiens_hsa04142 | 0.47711876 |
| 147 | Asthma_Homo sapiens_hsa05310 | 0.47679297 |
| 148 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47652226 |
| 149 | Gap junction_Homo sapiens_hsa04540 | 0.47652025 |
| 150 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47367027 |
| 151 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47276780 |
| 152 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46579279 |
| 153 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.45901089 |
| 154 | Purine metabolism_Homo sapiens_hsa00230 | 0.45839603 |
| 155 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45353590 |
| 156 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44776209 |
| 157 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44559877 |
| 158 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43912078 |
| 159 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43301557 |
| 160 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42143825 |
| 161 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41956835 |
| 162 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41742894 |

